Skandinaviska Enskilda Banken AB (publ) - SUPERNUS PHARMACEUTICALS INC ownership

SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 211 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 3.03 and the average weighting 0.1%.

Quarter-by-quarter ownership
Skandinaviska Enskilda Banken AB (publ) ownership history of SUPERNUS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$639
-23.9%
23,200
-16.8%
0.00%
-33.3%
Q2 2023$840
-99.4%
27,900
+298.6%
0.01%
+500.0%
Q3 2020$146,000
-91.8%
7,000
-90.7%
0.00%
-92.9%
Q4 2019$1,781,000
-8.6%
75,100
+5.9%
0.01%
-12.5%
Q3 2019$1,948,000
-17.1%
70,900
-0.1%
0.02%
-20.0%
Q2 2019$2,349,000
-16.9%
71,000
-12.0%
0.02%
-23.1%
Q1 2019$2,828,000
+13.3%
80,700
+7.5%
0.03%
+18.2%
Q4 2018$2,495,000
-35.9%
75,100
-2.8%
0.02%
-26.7%
Q3 2018$3,892,000
+27.3%
77,300
+51.3%
0.03%
+15.4%
Q2 2018$3,058,000
+3.5%
51,100
-20.8%
0.03%
-7.1%
Q1 2018$2,954,000
-6.3%
64,500
-18.5%
0.03%
+3.7%
Q4 2017$3,152,000
+32.5%
79,100
-17.8%
0.03%
+3.8%
Q3 2016$2,379,000
-51.1%
96,200
-59.7%
0.03%
-51.9%
Q2 2016$4,862,000
+4.8%
238,700
-21.5%
0.05%
+3.8%
Q1 2016$4,638,000
-15.6%
304,100
-25.6%
0.05%
-26.8%
Q4 2015$5,493,000408,7000.07%
Other shareholders
SUPERNUS PHARMACEUTICALS INC shareholders Q3 2020
NameSharesValueWeighting ↓
ASHFORD CAPITAL MANAGEMENT INC 698,676$41,816,0005.51%
Provident Investment Management, Inc. 543,194$32,510,0004.61%
NEUMEIER POMA INVESTMENT COUNSEL LLC 426,250$25,511,0002.37%
KOPP INVESTMENT ADVISORS LLC 41,879$2,506,0002.35%
AlphaOne Investment Services, LLC 126,279$7,558,0002.17%
Ranger Investment Management 468,933$28,066,0001.96%
Bruce & Co., Inc. 158,058$9,459,0001.88%
Penserra Capital Management LLC 244,371$29,030,0001.83%
SHAKER INVESTMENTS LLC/OH 49,642$2,971,0001.83%
Bridge City Capital, LLC 47,795$2,861,0001.81%
View complete list of SUPERNUS PHARMACEUTICALS INC shareholders